Hello and welcome to the Connecting Citizens to Science Podcast.
Kim Ozano:I'm Dr.
Kim Ozano:Kim Ozano.
Kim Ozano:This is a podcast about how communities and people join with researchers and scientists to
Kim Ozano:Please don't forget to like rate share and subscribe so that we can continue to share voices from around the
Kim Ozano:We hope you enjoy!
Kim:Hello listeners and welcome to the Connecting Citizens to Science Podcast.
Kim:We have a really important episode today.
Kim:We are going to be talking about female genital schistosomiasis, which affects approximately 56
Kim:I am here with co-host Pamela Mbabazi from the United Nations and guest Rhoda Ndubani, who is a study manager for a female
Kim:Victoria Gamba, who is a gynaecologist based in Kenya.
Kim:So let's start by saying hello to co-host Pamela.
Kim:Hi Pamela.
Kim:What is FGS?
Pamela:The easiest way to describe it, it's a damage of the female genital tract that results from the deposition of tiny
Pamela:This may sound like a big word, but more commonly people will know this as bilharzia, that's the easiest way to remember it.
Kim:And how do women and girls come across the parasite?
Pamela:The infection occur when women, girls, or even any individuals, uh, get in contact with infested water.
Pamela:So you may be out, going for a swim and, um, in a fresh water body that's infected, you could be going to do your regular chores, washing
Pamela:Just the fact that you have skin contact with an affected water body source where this parasite resides, it
Pamela:And that's how you get the infection.
Pamela:It is not a sexually transmitted infection despite the word, uh, female genital schistosomiasis, seeming to imply
Pamela:It is not.
Pamela:It's an infection that's acquired by getting in contact with infected water.
Kim:I know that there's stigmatisation around FGS because of the area where the infection occurs.
Kim:What is the impact of that stigmatisation, especially as often it's misdiagnosed as a sexually transmitted diseases.
Kim:What's the impact for women in the areas where it's prevalent?
Pamela:The main thing is that because of the anatomy that's affected, it's a private, intimate part of a human being.
Pamela:This is an aspect of our human existence as females for which we are valued in most social cultural contexts, your reproductive potential
Pamela:Stigma is a real issue.
Pamela:Related to that, of course, is mental health and several other consequences that accompany that.
Kim:Just to name a few of those consequences to set up the rest of the episode; I understand that it can
Kim:Is that right?
Pamela:That's absolutely right.
Pamela:I'll use one explanation to show you how terrible this infection is when you have it.
Pamela:Is that for every pair of worms that are circulating in your blood system, on average, each
Pamela:Just imagine if you have like 200 worms, now multiply that by 500.
Pamela:If you have 300 worms, a thousand worms, just keep the maths going and that equates into the equivalent of
Pamela:Every day.
Pamela:So just imagine what that would be like for you.
Pamela:It's a terrible, terrible condition to have.
Kim:Yeah, I think that analogy's really important to understand the severity and also to recognise that it's
Kim:Thank you for highlighting that.
Kim:But the good news is there is global action on FGS, and we have three great guests with us today, which I'm gonna
Pamela:Victoria, what do you know about FGS in the course of your work and how has this changed your own practice?
Victoria:Very good question.
Victoria:I'm an obstetrician and gynecologist practicing in Nairobi, Kenya.
Victoria:First and foremost, we knew about neuro genital schistosomiasis, all the way from undergraduate studies.
Victoria:However, the genital aspect has been very silent in most of the textbooks.
Victoria:You don't get to see exactly how it looks like.
Victoria:And even as we continued just doing our usual screening tests or speculum examination, the only thing we knew how
Victoria:If you don't know what it is, as long as it's not on the bad end of the spectrum, you allow the women to go home.
Victoria:At that point we still didn't know exactly how FGS presents or looks like during speculum examination, but then through our
Victoria:I think now it has influenced our practice to be more aware about how FGS looks like, whenever you're doing any screening
Pamela:Clearly you as a professional have had to address some misconceptions about, the disease.
Pamela:As you said, uh, basically a low clinical index of suspicion, which in the course of your work, you also
Pamela:Rhoda, what type of innovations, do you think, uh, could be done or are necessary to be able to overcome the type of
Rhoda:There's a lot of challenge to diagnose FGS in most of our health facilities due to limited resources and of course equipment.
Rhoda:I must say, in one of studies we did on FGS, one of the things that we actually did identify was the
Rhoda:FGS is not something that is routinely tested in the health facility.
Rhoda:So if a woman presents those symptoms, the first test that will be given is either on sexually transmitted infections or UTI.
Rhoda:So already there is that barrier and also chances of being misdiagnosed.
Rhoda:Also resources are also lacking in these public health facilities.
Rhoda:So there's need for more resources and also more equipments that could help diagnose FGS at the moment in most of the health
Pamela:How can science and research make sure that we bridge this knowledge gap such that a woman is able to get a diagnosis
Rhoda:I think one of the things we could do to improve on that is of course, provide the women
Rhoda:First of all to find out how can they get the parasite, what can they do to prevent getting the parasite?
Rhoda:And also where can they go to seek health services if they have FGS.
Rhoda:I think it's impacting that knowledge amongst community members that will help us in the long run to fight FGS.
Rhoda:Once the community's aware about it, they know how to prevent FGS, or they know where they can seek services for FGS, I think
Pamela:One can't help but think of self-testing as well as a possible option.
Pamela:The testing for Covid-19 was quite rigorous, but now it's the diagnostics and research has moved to
Pamela:Do you see that becoming a possibility in the future?
Rhoda:In the studies that I've worked on, in the study that I'm currently working on, we are using the
Rhoda:This is done in the community at household level as well as the health facility.
Rhoda:When we go in the households to provide the self sampling tests, you have to, first of all give the women the knowledge on FGS
Rhoda:We've noticed in the study is that there's high acceptability of the self-test, which is very positive.
Rhoda:Of course there could be challenges with, uh, providing these self-test kits, the costs, those, um, limited resources, I
Pamela:We hope to see that something like that actually comes into reality.
Pamela:And then you can look back to us, to WHO, to work with our partners and figure out how to look for subsidies and work with governments
Pamela:Victoria, which innovative ways do you see us trying to actually get the gynecologists in our type of settings to engage more on FGS?
Victoria:The most important thing at this point is to remember you're dealing with women.
Victoria:So when you use a human-centered approach or a human lens, when you look at that woman, she carries a lot of things.
Victoria:She might have a breast disease, she might have uterine disease, she might have all this.
Victoria:And I want to thank all the stakeholders that have put forward, you know, different programmes that are bit siloed at the moment,
Victoria:For sure that woman won't come back.
Victoria:So to ensure that continuity is there, I think number one is, leveraging on the existing programmes that are available...
Pamela:mm-hmm.
Victoria:...and just looking for ways where we can integrate things because I mean, um, you're a woman, going
Pamela:mm-hmm.
Victoria:...so you can imagine having to do like different speculum examination for each clinician that you see.
Victoria:So if there's any way that we can be able to have the integrated algorithm, or this is how FGS looks like; if you're screening
Victoria:Basically it's more about calls for integration and being accountable to these women.
Victoria:I think, uh, we ought to give them what they deserve.
Pamela:Indeed.
Pamela:You have highlighted several ways in which possibly there are latent opportunities that we are underutilising,
Pamela:And indeed, WHO put aside some guidelines of how this could be done over the life course.
Pamela:We need to be centered on the woman as a whole, not, not an anatomy or a disease per se.
Pamela:So from Christine would like to hear, what would be your suggestions from the perspective of a community social scientist; how do you see
Christine:Young girls are in a community, so the idea of this podcast being about reaching communities is important
Christine:In most cases, the young girls are either under older women or under men; husbands or fathers or uncles.
Christine:There is something important reaching out to the whole community as one, letting the information go further than just the
Christine:So I think there's a lot about sensitisation on a large community at once, not just targeting young
Pamela:Again, we know that knowledge is power.
Pamela:We need to empower women.
Pamela:We need to empower girls, not only to strengthen the agency that they already have themselves, but also to be stronger placed to
Pamela:So what are some of the ways you see this being done in a manner that's sustainable and effective in the
Rhoda:We use drama performances to raise awareness about FGS in the community amongst the girls and women and also to inform women
Rhoda:We did train a drama group in the community, the drama group went and performed drama scripts relating to FGS.
Rhoda:We did get quite a good response from the women, um, after they learnt more about FGS through the drama.
Rhoda:And I must say that during the drama performance, you could see women, um, asking more questions.
Rhoda:When we talked about the symptoms for FGS, they became very attentive and asked a lot of questions about that.
Rhoda:Later on they would actually accept to go and be tested for FGS.
Rhoda:I must say that, um, you know, as we raise this awareness, as we give this knowledge about FGS to
Rhoda:Looking at our African context, there are times where a woman needs to get permission from their spouses, to go and have some of these tests.
Rhoda:So as we did the drama, we also, uh, tried to invite the men's also to come for these, uh, performances
Rhoda:We also engaged quite a number of community leaders, which I think is also very important as you
Rhoda:It's also good to engage the community leaders.
Rhoda:The men were also invited.
Rhoda:During these drama performances, we also produced brochures...
Pamela:mm-hmm,
Rhoda:...uh, that had more information about FGS, which we gave out to the men, but also even the women, they also asked for
Rhoda:I would say it's very important to bring in all these strategies.
Pamela:Thank you so much once again, Rhoda, for highlighting the intersectionality with several other things that
Pamela:While we address these issues, we know that um, we really need our males to also step up and be part of this.
Pamela:We know that to address FGS, we also need the agency and participation of males.
Christine:There is the issue around power and gender decision making is mostly in the hands of men, in most of the cultures, for
Christine:This is something the men have more of a monopoly on.
Christine:I think there is the gender dynamics and there are also other things that play a huge role there, but empowering
Pamela:Thank you so much for all your insights.
Kim:Thanks Pamela.
Kim:That was a wonderful conversation.
Kim:Rhoda.
Kim:Could you give us one piece of advice for those working in FGS and trying to reach communities.
Rhoda:It's very important to engage communities as we do research.
Rhoda:One of the things is bringing on board, uh, the different community stakeholders within the community.
Rhoda:As you start your project, make sure that the community leaders, uh, community-based organisations are involved at the beginning of the
Rhoda:It is also important to make sure that you give out more information, the right information about your research to
Rhoda:At the end of the day, uh, it's what gives you the positive response and the best results for your research.
Kim:Victoria, please, one piece of advice for others in your position.
Victoria:One of the things that I do want to bring out is, as Rhoda has said, it's mostly about engaging all stakeholders
Victoria:It brings about continuity.
Victoria:It allows you to penetrate further into the communities.
Victoria:And at the end of the day, you also have to listen.
Victoria:I know we do come up with, um, approaches that are textbook, but you also have to listen, look,
Victoria:What are their challenges?
Victoria:Why are they doing certain activities so that, you know, you bring about an intervention that can work and it's
Kim:Great.
Kim:So generate that demand and make sure that the programmes are sustainable long-term.
Kim:Wonderful.
Kim:Mm-hmm.
Kim:and Christine, one piece of advice, please.
Christine:The first thing is to encourage anybody wanting to work in communities, to reach out to communities, because
Christine:This means meeting the people themselves, working with their social structures, engaging with them at once.
Christine:The idea of ownership is something which is key for us in social science because I won't just come
Christine:You have the traditional health workers, you have the traditional birth attendance.
Christine:These are ladies who know the communities, they know the people.
Christine:Once you meet these women and explain what you want to do, that's already a huge step in getting access to other women.
Christine:So there's a whole mechanism, which is based within communities and just a bit of understanding, stakeholder mapping around these
Kim:And finally, to take us home.
Kim:Pamela, what piece of advice would you like to end the show on?
Pamela:I would like to point out that uh, the WHO member states have endorsed a roadmap for addressing
Pamela:In this we have a goal to eliminate morbidity due to schistosomiasis and female genital schistosomiasis is one of them.
Pamela:This goal is very well aligned also with the intention to eliminate cervical cancer by the year 2070 so it'll be a shame
Pamela:I would call on everyone to familiarise themself with the strategic document that's been put out and the
Pamela:Preventive, chemotherapy, treat, treat, treat, treat.
Pamela:Treat people with Praziquantel.
Pamela:Don't wait for diagnosis.
Pamela:Treat upon suspicion.
Pamela:Treat water and sanitation.
Pamela:We need to give people better water, and most importantly also for those that have established morbidity, we really
Kim:Thank you Pamela.
Kim:Wonderful pieces of information there for, for the audience to act on and, um, some calls to action as well.
Kim:So thank you to all of our guests today and the wonderful co-host, Pamela, thank you for your participation.
Kim:And to our audience and our listeners, please don't forget to like, rate, share, and subscribe so we can continue to bring the
Kim:Thank you very much, and bye for now.
Kim:Bye everyone.
Rhoda:Bye.
Rhoda:Thank you so much.
Rhoda:Bye-bye.